The use of a hybridization assay for the study of host defences against herpes simplex virus. 1989

A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
Eijkman Winkler Laboratory for Medical Microbiology University Hospital Utrecht, The Netherlands.

A rapid and simple hybridization assay was developed as an alternative for virus titration for the investigation of host resistance against HSV-1 infections in vitro. The probe which was constructed for this assay was shown to be HSV-1-specific. When a monolayer of fibroblasts was infected for 24 h before hybridization, 15 PFU were detected reliably. A plateau in hybridization levels was found when the multiplicity of infection reached 1. In order to demonstrate the applicability of the probe for the study of host defences against HSV in vitro, fibroblasts were infected with HSV in the presence of different numbers of adherent cells and different concentrations of serum containing high titres of anti-HSV antibodies and complement. After 20 h of incubation, samples were lysed, spotted on Zetaprobe filter paper and hybridized with a 32P-labelled RNA probe. Spots were counted for radioactivity. The radioactivity was taken as a measure of the success of infection. Results showed that at high (10%) concentrations of serum containing high titres of anti-HSV antibodies and complement neutralization plays an important role. At low (1%) concentrations of serum containing high titres of anti-HSV antibodies and complement the phagocytic role of adherent cells becomes the dominant factor in preventing infection of the fibroblasts. However, when the number of infectious particles is increased, the protection provided by adherent cells is overwhelmed.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene

Related Publications

A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
August 1984, Microbiological sciences,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
March 1992, Journal of clinical microbiology,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
August 2002, Pathologie-biologie,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
January 1985, British medical bulletin,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
November 1979, CRC critical reviews in microbiology,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
January 2020, Journal of immunology research,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
December 1993, Pediatric annals,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
April 1990, Journal of virological methods,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
June 2004, Current opinion in infectious diseases,
A C Fluit, and J A van Strijp, and L A Miltenburg, and C P van Kessel, and H Snippe, and J Verhoef
November 1989, Journal of virology,
Copied contents to your clipboard!